Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2021-03-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事2020年度述职报告(徐永光)
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2020 Annual Report" and contains a detailed report of the independent director's activities, attendance, opinions, and oversight during the year 2020. It includes descriptions of meetings attended, independent opinions on various company matters, investigations, committee roles, and efforts to protect investor rights. The document is a narrative report on the independent director's duties and performance rather than a financial report or announcement. It is not a full annual report (10-K), audit report, or regulatory filing. It is a management or governance-related report focusing on the independent director's role and oversight. Therefore, the most appropriate classification is Board/Management Information (MANG), which covers announcements or reports related to company board members and senior management activities.
2021-03-30 Chinese
关于高级管理人员退休的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the retirement of a senior management member (vice president) due to reaching retirement age. It includes statements about the individual's departure and the company's acknowledgment of their contributions. There is no financial data, no mention of a report or meeting, and it concerns a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2021-03-25 Chinese
关于非公开发行股票募集资金专用账户销户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the closure of fundraising accounts related to non-public stock issuances by the company. It details the amounts raised in 2016 and 2019 through non-public stock offerings, the use and management of the raised funds, and the formal closure of the dedicated fundraising accounts. The document references approvals from the China Securities Regulatory Commission and includes verification reports from an accounting firm. The content focuses on capital raising activities and the management of those funds, specifically the closure of accounts used for the raised capital. It does not contain financial statements, earnings data, or detailed management analysis, nor is it a report or presentation. It is an update on financing activities and capital management, fitting the category of Capital/Financing Update (CAP). The document length is 3158 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is CAP with high confidence.
2021-03-18 Chinese
2019年度报告补充公告
Remuneration Information Classification · 95% confidence The document is a supplementary announcement related to the 2019 annual report, specifically disclosing additional details about the pre-tax remuneration of senior management for that year. It is not the full annual report itself but an additional disclosure or update related to compensation information. The document is short (779 characters) and focuses on remuneration details rather than the full financial performance or comprehensive report. According to the filing definitions, detailed compensation information for executives is classified under Remuneration Information (DEF 14A). Therefore, this document fits best under the Remuneration Information category.
2021-03-16 Chinese
安理律师事务所关于嘉事堂药业股份有限公司2021年第一次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2021 first extraordinary general meeting (EGM) of shareholders of Jia Shi Tang Pharmaceutical Co., Ltd. It details the legality and validity of the meeting's convening, attendance, voting procedures, and results. The document includes voting results on proposals such as the use of idle raised funds and the election of independent directors. It is not a full annual or interim report, nor is it a simple announcement. It is a legal opinion related to a shareholders' meeting and the voting results therein. This fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting with detailed vote counts and outcomes.
2021-03-15 Chinese
2021年第一次临时股东大会决议暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official announcement from a company regarding the resolutions and voting results of its 2021 first extraordinary general meeting (临时股东大会). It details the meeting date, attendance, voting procedures, and the results of the votes on specific proposals, including the election of independent directors and the use of idle raised funds. The document also includes legal opinions confirming the validity of the meeting and its resolutions. There is no detailed financial data or comprehensive report content, but rather a formal disclosure of voting outcomes and meeting resolutions. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. The document length is 2736 characters, which is relatively short and consistent with a voting results announcement rather than a full report or presentation.
2021-03-15 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.